Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines by unknown
TUMOR NECROSIS FACTOR a/CACHECTIN IS A
GROWTH FACTOR FOR THYMOCYTES
Synergistic Interactions with Other Cytokines
By GERALD E. RANGES,* ALBERT ZLOTNIK,- TERJE ESPEVIK,*
CHARLES A. DINARELLO,§ANTHONY CERAMI,° AND
MICHAEL A. PALLADINO, JR*
From the *Department of Molecular Biology and Immunology, Genentech, Inc ., South San
Francisco, California 94080 ; the *Department of Immunology, DNAX Research Institute, Palo
Alto, California 94304 ; the DDepartment of Medicine, New Englant,' Medical Center, Boston,
Massachusetts 02111 ; and the ~IDepartment ofMedical Biochemistry, The Rockefeller University,
New York, New York 10021
TNF-a/cachectin, initially described for its ability to induce hemorrhagic
necrosis in vivo (1), also exerts profound effects on several biological processes
shared with IL-1, including endogenous pyrogen activity, stimulation of bone
resorption, collagenase and prostaglandin Ez synthesis by fibroblasts (2), IL-2-R
expression and T cell growth (3) . Among those activities which have not been
reported to be shared between IL-1 andTNF-a are the ability to stimulate thy-
mocyte proliferation. The purpose of our study was to determine the effects of
TNF-a on the in vitro proliferative response of murine thymocytes .
Materials and Methods
Reagents. Recombinant murine TNF-a (rmTNF-a) and recombinant human TNF-a
(rhTNF-a) were cloned and expressed in Escherichia coli (4, 5) (specific activities 5 X 10 7
and 7 X 10 7 U/m~of protein, respectively) . Recombinant murine interferon y (rmIFN-
y, sp act 1-2 X 10 U/mg of protein) was cloned and expressed in E. coli (6) . By limulus
amoebocyte lysate assays, the recombinant proteins were found to contain
<0 .025 pg of endotoxin/Ag of protein . Natural murine TNF-a had a specific activity of
2 X 10 7 U/mg protein (7) . Purified natural human IL-1 (specific activity 107 U/mg pro-
tein) was obtained from Genzyme (Boston, MA) . Human rIL-2 (sp act 107 U/mg protein)
was obtained from Boehringer Mannheim Biochemicals (Indianapolis, IN) . Murine rIL-
4 (sp act 10 7 U/mg protein) was obtained from DNAX Research Institute (Palo Alto,
CA) .
Thymocyte Comitogenic Assay .
￿
C3H/Hej thymocytes (The Jackson Laboratories, Bar
Harbor, ME) were cultured in 96-well flat-bottomed culture plates (1 .5 X 106/0.1 ml)
(Costar, Cambridge, MA) in Eagle's MEM supplemented with 1% nonessential amino
acids, 10% heat-inactivated FCS (HyClone Laboratories, Loan, UT), 1% i.glutamine,
100 U/ml penicillin, 100 pg/ml streptomycin, and 5 X 10 - M 2-ME (CMEM) in the
presence of a 1 :2,000 final dilution of phytohemagglutinin P (PHA-P, Difco Laborato-
ries, Detroit, MI) . Cytokines were added to a final volume of 0.2 ml . After 60 h at 37°C,
cultures were pulsed with 1 ACi[3H] thymidine (5 Ci/mmol ; New England Nuclear, Bos-
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Volume 167 April 1988 1472-1478ton, MA) for 12 h, harvested onto glass fiber filters (PhD, Cambridge Technology, Inc .,
Watertown, MA), and mean [aH] thymidine incorporation (cpm) of triplicate cultures was
determined .
TNF-a Bioassay.
￿
TNF-a activity was assayed on WEHI-164 clone 13 cells (8) . This
assay is sensitive to 10 fg/ml of mTNF-a . Rabbit anti-rmTNF-a, developed by methods
similar to those described for rabbit antibodies to rhTNF-a, has a neutralization titer of
106 U/ml (9) .
Results and Discussion
As shown in Fig . 1 A, rmTNF-a but not rhTNF-a (even at doses as high as
105 U/ml) stimulates thymocyte proliferation in the presence of PHA-P, albeit
(on a unit per unit basis) to a significantly lesser degree than IL-1 . At the doses
tested, natural mTNF-a/cachectin shows similar stimulatory effects compared
with rmTNF-a on thymocytes (Fig . 1 B) (7) . Previous studies using mTNF-a/
cachectin were performed at concentrations below those required to stimulate
thymocyte proliferation, which may explain the failure of earlier studies to
detect proliferative activity by thymocytes (10) . While species preferences for
TNF-a activities have been observed (5, 11), the species specificity displayed on
thymocytes was unexpected and explains the failure by previous studies (12) to
detect thymocyte activation by this cytokine . mTNF-0 was not available for test-
ing, but rhTNF-0 (lymphotoxin), like rhTNF-a, was not active in this assay (data
not shown) .
Previous studies have indicated that human TNF-a competes with mTNF-a for
receptor binding on murine cells (11) . As it was of interest to determine whether
the failure of rhTNF-a to induce murine thymocyte proliferation was due to the
inability to specifically bind to thymocytes, competition assays were performed
to determine whether rhTNF-a could inhibit the modulation of thymocyte pro-
liferation by rmTNF-a . The results demonstrated that rmTNF-a-induced thy-
mocyte proliferation was inhibited, in a dose-dependent manner, by rhTNF-a
(Fig . 2) . The amounts of rhTNF-a required to achieve this suppression were 5-
10-fold higher than the amount of rmTNF-a signaling proliferation, suggesting
that rhTNF-a may bind to the TNF receptor with less affinity than rmTNF-a
(11) .
Several recent studies indicate that TNF-a can synergize with one or more
lymphokines during the induction of certain biological activities (3, 13) . The fol-
lowing studies were designed to determine whether rMuTNF-a could synergize
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FIGURE 1 . (A) rmTNF-a but not
rhTNF-a enhances murine thymo-
cyte proliferation . rmTNF-a (0),
rhTNF-a (A), or hIL-1 (O) were
added at the indicated concentra-
tions . mAbs to rmTNF-a abolished
the proliferative effects of rmTNF-a
on murine thymocytes (data not
shown) . (B) Both natural and
rmTNF-a enhance PHA-P-induced
murine thymocyte proliferation .
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FIGURE 2. Competitive inhibition of rmTNF-a-
induced thymocyteproliferationby rhTNF-a. rmTNF-a:
(0), 2,500 U/ml; (0) 1,250 U/mI; (0) 625 U/ml; (a)
313 U/ml were assayed in the presence of PHA-P and
in the absence or presence of rhTNF-a concentrations
ingfrom 1.3 X 10'-5.0 X 105 U/ml.
with several lymphokines known to have immunologic activity in the thymocyte
comitogenic assay (Fig. 3). Both hIL-I and rhIL-2 induced thymocytes to pro-
liferate in the absence or presence of PHA-P although rhIL-2 was far more
potent under either condition. rmIFN-,y was ineffective at inducing activity
whether of not PHA-P was present. When rmTNF-a was added to cultures con-
taining either hIL-I or rhIL-2, the response was enhanced substantially beyond
additive responses of the two lymphokines alone, both in the absence and pres-
ence of PHA-P.
As rmIL-4 is also comitogen
relationships of rmTNF-a and rmIL-4 in augmenting thymocyte proliferation
(Fig. 4). The data indicate that rmIL-4 is mitogenic for marine thymocytes,
albeit to a much greater degree in the presence of PHA-P. In contrast to the
results obtained with hIL-1 or rhIL-2, the addition of rmTNF-a did not enhance
the mitogenic signal of rMuIL-4 alone, and only marginally increased the pro-
liferative response of thymocytes to rmIL-4 in the presence of PHA-P beyond
the additive response of the two lymphokines alone.
Among the lymphokines that are comitogenic for thymocytes in the presence
of PHA-P are IL-1, IL-2, and IL-4 (14, 15). To test whether n-nTNF-a was either
directly comitogenic or indirectly by stimulating the synthesis of one or more of
these lymphokines which in turn acted directly on the thymocytes, supernatants
were assayed from rmTNF-a/PHA-P-activated thymocyte cultures for the pres-
ence of these factors. The IL-1 assay, performed with subclone D10.5 of the
marine helper T cell line, DIO.G4.1, is sensitive to 1-10 fg/ml of IL-la or IL-
10 (16). The IL-2 and IL-4 assays, performed on HT-2 cells, are sensitive to
0.15 U rhIL-2/ml and I U rIL-4/ml (17). The levels of IL-1, IL-2, and IL-4 in
supernatants from rmTNF-a/PHA-P-activated thymocyte cultures were below
the detection limit for these assays. Because the levels of lymphokines detectable
by these assays fall below those levels that synergize with rmTNF-a, our results
suggest that the proliferative response by thymocytes to TNF-a does not require
the intermediate production of any of these lymphokines.
Having established that rmTNF-a provides a comitogenic signal for thymocyte
proliferation, we examined whether rmTNF-a was produced by thymocytes stim-RANGES ET AL.
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Interactions between hIL-I, rhIL-2, or rmIFN--f with rmTNF-a. hIL-I, rhIL-2
and rmIFN-y were used at the indicated doses in the absence (" ) or presence (©) of 1,000
U/ml of rmTNF-a and in the absence or presence of a 1:2,000 final dilution of PHA-P.
['H]thymidine incorporation of thymocytes stimulated with 1,000 U/ml of rmTNF-a alone
(O) or with rmTNF-a in the presence (") of a 1:2,000 Final dilution of PHA-P was 874 and
22,008 cpm, respectively.
ulated with either PHA-P alone or in conjunction with hIL-1, rhIL-2, or rmIL-
4. Previous reports have indicated the T cells from human peripheral blood can
be induced to produce TNF-a (18). The results indicate that rmTNF-a was pro-
duced by PHA-P stimulation alone and that the addition of hIL-1, rhIL-2, or
rmIL-4 at concentrations that induce significant thymocyte proliferation
resulted in an augmentation of mTNF-a production (Table 1).
The data presented here suggest that TNF-a, as well as other lymphokines,
may play an important role in thymocyte proliferation and differentiation (17,
18). Our observations indicate that mTNF-a is not directly mitogenic for thy-
mocytes but acts as a comitogen with
thymocytes by mTNF-a is not yet clear,
ulatory levels of mIL-1, mIL-2, or mIL-4 in
rmTNF-a and PHA-P suggests that the production of these lymphokines is not
HA-P. The mechanism of
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￿
Interactions between hIL-I or rmIL-4 with rmTNF-a. hIL-1 and rmIL-4 were
used at the indicated doses in the absence (M) or presence (O) of 1,000 U/ml of rmTNF-a
and in the absence or presence of a 1 :2,000 final dilution of PHA-P. ['H]thymidine incor-
poration of thymocytes stimulated with 1,000 U/ml rmTNF-a alone (O) or rmTNF-a in the
presence (") of a 1:2,000 final dilution of PHA-P was 1,940 and 57,590 cpm, respectively.
intermediate to this process. Alternatively, stimulation of thymocytes by these
lymphokines in the presence of PHA-P is accompanied by the production of
significant amounts of mTNF-a, possibly implicating mTNF-a as a common
intermediate in thymocyte activation initiated by these materials.
TABLF I
Cytokine-induced TNF-a Production by Murine Thymocytes
* C3H/Hej thymocytes (1.5 X 107/ml) were stimulated with PHA-P (1 :2,000
final dilution) aloneor with theindicatedconcentrations of cytokines. After48
h ofculture at 37°C, supernatants were assayed formTNF-a activity on WEH I-
164 clone 13 cells (11) .
" Rabbit anti-rmTNF-a serum (at a 1:30 dilution) wasadded to the supernatants
30 minbefore assay. Normal rabbit serum at 1:30 dilution showed no anti-TNF-
a activity or interference in this assay.
m`fNF-a (U X 10 -'/ml) ± SD
Thymocyte treatment*
Alone Anti-rmTNF-a'
None 0.27 ± 0.04 1.0 ± 0.01
PHA-P 4.2 ± 0.4 0.67 ± 0.01
PHA-P + 5 U/ml lilt-1 9.3 ± 1.0 0.92 ± 0.08
PHA-P + 5 U/ml rhIL-2 24 .6 ± 1.2 1.07 ± 0.42
PHA-P + 250 U/ml rmIL 4 11 .0 ± 1.5 0.83 ± 0.01RANGES ET AL.
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We have recently observed that rmTNF-a will induce production of substan-
tial amounts of IL-6 by murine thymocytes and that IL-6 can act as a comitogen
for thymocyte proliferation in the presence of PHA-P (unpublished observa-
tions). Investigations are in progress to determine the role of these factors in
thymocyte proliferation and development.
Summary
Recombinant murine (rm) TNF-a but not recombinant human (rh) TNF-a
induces the proliferation of murine thymocytes in the presence of a comitogenic
stimulus. This effect does not appear to be due to the production of significant
levels of IL-1, IL-2, or IL-4 . Although not directly mitogenic (i .e., in the absence
of PHA-P) for thymocytes, rmTNF-a amplifies the direct mitogenic signals from
hIL-1 and rhIL-2 but not rmIL-4. In the presence of PHA-P, thymocytes stim-
ulated with hIL-1, rhIL-2, and rmIL-4 produced significant amounts of TNF-
a. Although rhTNF-a does not induce a proliferative response, it will competi-
tively inhibit the proliferative response of thymocytes to rmTNF-a. These data
suggest a critical role for TNF-a in the intrathymic proliferation of developing
T cells.
Receivedfor publication 7 December 1987 and in revised form 27 January 1988.
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